Detalhe da pesquisa
1.
Hyper-CVAD versus dose-adjusted EPOCH as initial treatment for adults with acute lymphoblastic leukemia.
Eur J Haematol
; 111(6): 863-871, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37670560
2.
A novel GAB2::BRAF fusion in cutaneous non-Langerhans-cell histiocytosis with systemic involvement.
J Cutan Pathol
; 49(8): 727-730, 2022 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-35332933
3.
The response to lymphodepletion impacts PFS in patients with aggressive non-Hodgkin lymphoma treated with CD19 CAR T cells.
Blood
; 133(17): 1876-1887, 2019 04 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-30782611
4.
Survival of patients with newly diagnosed high-grade myeloid neoplasms who do not meet standard trial eligibility.
Haematologica
; 106(8): 2114-2120, 2021 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32646891
5.
Financial Implications of Early Hospital Discharge After AML-Like Induction Chemotherapy: A 4-Year Retrospective Analysis.
J Natl Compr Canc Netw
; : 1-10, 2021 Jun 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-34161925
6.
Histiocytic Neoplasms, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology.
J Natl Compr Canc Netw
; 19(11): 1277-1303, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34781268
7.
Managing Cancer Care During the COVID-19 Pandemic: Agility and Collaboration Toward a Common Goal.
J Natl Compr Canc Netw
; : 1-4, 2020 03 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-32197238
8.
Aleukemic mast cell leukemia, well-differentiated and chronic type.
Ann Hematol
; 102(6): 1613-1615, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37016166
9.
Description and prognostic significance of the kinetics of minimal residual disease status in adults with acute lymphoblastic leukemia treated with HyperCVAD.
Am J Hematol
; 93(4): 546-552, 2018 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-29318644
10.
Development of a hematology/oncology ICD-10 documentation job aid.
J Natl Compr Canc Netw
; 13(4): 435-40, 2015 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-25870380
11.
Idarubicin, cytarabine, and pravastatin as induction therapy for untreated acute myeloid leukemia and high-risk myelodysplastic syndrome.
Am J Hematol
; 90(6): 483-6, 2015 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-25689471
12.
G-CSF priming, clofarabine, and high dose cytarabine (GCLAC) for upfront treatment of acute myeloid leukemia, advanced myelodysplastic syndrome or advanced myeloproliferative neoplasm.
Am J Hematol
; 90(4): 295-300, 2015 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-25545153
13.
Outpatient bendamustine and idarubicin for upfront therapy of elderly acute myeloid leukaemia/myelodysplastic syndrome: a phase I/II study using an innovative statistical design.
Br J Haematol
; 166(3): 375-81, 2014 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-24749757
14.
Gemtuzumab ozogamicin in combination with vorinostat and azacitidine in older patients with relapsed or refractory acute myeloid leukemia: a phase I/II study.
Haematologica
; 99(1): 54-9, 2014 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-24142996
15.
Phase I/II trial of cladribine, high-dose cytarabine, mitoxantrone, and G-CSF with dose-escalated mitoxantrone for relapsed/refractory acute myeloid leukemia and other high-grade myeloid neoplasms.
Haematologica
; 104(4): e143-e146, 2019 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30409798
16.
Unsatisfactory efficacy in randomized study of reduced-dose CPX-351 for medically less fit adults with newly diagnosed acute myeloid leukemia or other high-grade myeloid neoplasm.
Haematologica
; 103(3): e106-e109, 2018 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-29242304
17.
Are new oral anticoagulants ready for use in patients with cancer?
J Natl Compr Canc Netw
; 11(11): 1446-9, 2013 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-24225975
18.
Poor post-induction outcomes in patients with acute myeloid leukemia previously treated with hypomethylating agents.
Leuk Lymphoma
; 64(5): 990-996, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36891630
19.
Phase II study of dose-adjusted EPOCH as initial therapy for adults with high-risk acute lymphoblastic leukemia.
Leuk Lymphoma
; 64(5): 927-937, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36938892
20.
Phase 1/2 study of sorafenib added to cladribine, high-dose cytarabine, G-CSF, and mitoxantrone in untreated AML.
Blood Adv
; 7(17): 4950-4961, 2023 09 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37339483